Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-5350517
  • Global Bone Graft and Substitute Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: May 2017 | Report Code: HPH-5350517

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The global bone grafts and substitutes market is anticipated to grow at a CAGR of 4.7% during 2016 to 2023.. During a bone graft, a piece of bone is added to the place of a fracture or other bone imperfection. The value of bone transplantation is proved by the rate of its use. . Surgeons transplant bone as a minimum of 10 times more often than they do any other transplantable organ. Repeated efforts to grow enhanced allografts such as demineralized bone matrix grafts with greater osteoinductive and osteoconductive capabilities which are estimated to have an encouraging impact on the growth of the bone grafts and substitutes market during the forecast period. The major factors which are driving the bone graft and substitute market are rising incidences of musculoskeletal conditions due to sudden exertion and repetitive strain, increasing base of elderly population, development of biocompatible synthetic bone grafts. The major restraints of the bone grafts and substitutes market are high cost of surgeries, and the stringent regulatory approval process.

The global bone grafts and substitutes market is segmented into its application and type. The application segment of the bone grafts and substitutes market is further divided into spinal fusion, foot and ankle, long bone,  craniomaxilofacial, joint reconstruction, dental. The type segment of bone grafts and substitutes market is further divided into bone graft substitutes and allografts. Utilization of bone graft and substitute was pragmatic to be the maximum in spinal fusion surgeries amongst other applications. Since there is increased demand for spinal fusion surgeries due to the rising geriatric population attached with the demand for minimally invasive surgeries is the leading factor prompting the demand for bone graft and substitute in spinal fusion surgeries. It is estimated that 96% of patients with degenerative spondylolisthesis experience fusion surgery as an aid to decompression surgery in the United States. The ideal bone graft and substitute should offer three essential elements an osteo-inductive properties or factors, osteoconductive matrix, and osteogenic cells.

 Constant efforts to develop and enhanced allografts for example demineralized bone matrix grafts with greater osteoinductive and osteoconductive abilities are expected to have a constructive impact on the development of the market during the forecast period. Rapidly thriving dental tourism industry and comparatively low cost of the surgeries are some of the important factors driving the growth of the dental application segment. Medical tourism and the dental tourism is where people from one country seek medical, dental or surgical care in some other country such as India and China. People seek care in these countries because of affordability, receiving greater care than they would have received in their own country and the treatment is cost efficient in developing countries instead of developed countries. This is also one of the major factor driving the bone graft and substitute market in developing countries. Medical tourism is majorly and positively impacting the pharmaceuticals and medical industries and is also impacting the society in the emerging countries. In developing countries, the demand for medical and healthcare facilities is increasing which brings increased investments in the sector and efforts to improve the infrastructure and quality of care being provided. This results in increased employment opportunities for natives and thus created the way for industrial as well as social growth. It is estimated that the global medical tourism industry produces between $45 and $72 billion every year. In India, medical tourism is a growing sector. In 2015, Indian medical tourism sector was around $ 3 billion, and is anticipated to grow around $8 billion by the year 2020. The rise in aging population is also drives the bone graft and substitute market at a great extent, since the risks associated with musculoskeletal conditions increase with age. It is estimated that the number of Americans ages 65 and older was around 46 million in the year 2016 and it is anticipated to be around 98 million by the year 2060. The world’s older population endures to grow at an extraordinary rate. In the year 2015, 8.5 % of people worldwide are aged 65 and over which is around 617 million and it is anticipated that it will increase nearly 17% of the world’s population by the year 2050.

Based on geography, the global bone grafts and substitutes market is segmented into North America, Europe, Asia-Pacific and Row. North America was expected to be the leading market for bone grafts and substitutes in the year 2016.  North America was chiefly accredited to high awareness regarding commercially available products, the accessibility of advanced infrastructure and greater healthcare expenditure. The United States per capita healthcare expenditure is valued to be $9024 which is more than twice the average as compare to the other developed countries. APAC is expected to lead the market in coming years due to increased healthcare spending in the region. Improved healthcare sector is one of the major factor which has increased medical tourism in APAC region and is the key growth factor for APAC bone graft and substitutes market. The major players of the bone grafts and substitutes market are Allosource, Baxter International, Depuy Synthes, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic Plc, Musculoskeletal Transplant Foundation, Nuvasive, Inc., Orthofix Holdings, Inc., Orthovita, Inc., Stryker Corporation, Smith & Nephew, Inc, Wright Medical Group N.V, Xtant Medical Holdings, Inc., Zimmer Biomet Holdings, Inc. Acquisition, merger, innovation and new product launch are the major strategies which help to sustain in the market. On December 19, 2016 Kuros Biosciences is acquire Xpand Biotechnology, the collective entity expects to feat two complementary technologies Kuros’s fibrin/PTH biologics platform and Xpand’s synthetic surface science technology. This acquisition is Form Orthobiologics Firm with Bone Graft Substitute. 

TABLE OF CONTENTS
 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING INCIDENCES OF MUSCULOSKELETAL CONDITIONS
3.1.2. INCREASING BASE OF ELDERLY POPULATION
3.1.3. DEVELOPMENT OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
3.1.4. TECHNOLOGICAL ADVANCEMENTS
3.1.5. OBESITY AND DIABETES INCREASE THE RISK OF DEGENERATIVE JOINT DISEASES
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF SURGERIES
3.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES.
3.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS.
3.3. MARKET OPPORTUNITIES
3.3.1. GOVERNMENT FOCUSING ON THE DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
3.3.2. INCREASING INVESTMENTS IN THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
3.4. MARKET CHALLENGES
3.4.1. RISK RELATED WITH IMMUNE RESPONSE
3.4.2. RISK WITH DISEASE TRANSMISSION
 
4. MARKET SEGMENTATION
4.1. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL ALLOGRAFTS MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL BONE GRAFT SUBSTITUTES MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.2. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL SPINAL FUSION MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL LONG BONE MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL FOOT AND ANKLE MARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.4. GLOBAL CRANIOMAXILOFACIAL MARKET
4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.4. KEY CONCLUSIONS
4.2.5.5. GLOBAL JOINT RECONSTRUCTION MARKET
4.2.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.4. KEY CONCLUSIONS
4.2.5.6. GLOBAL DENTAL MARKET
4.2.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY REGION
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.3. FRANCE
6.4.2.3.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.3.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.3.1.3. KEY CONCLUSIONS
6.4.2.3.2. GERMANY
6.4.2.3.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.3.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.3.2.3. KEY CONCLUSIONS
6.4.2.3.3. SPAIN
6.4.2.3.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.3.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.3.3.3. KEY CONCLUSIONS
6.4.2.3.4. REST OF EUROPE
6.4.2.3.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.3.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.3.4.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.1.2. TOP COUNTRY ANALYSIS
6.4.4.1.3. LATIN AMERICA
6.4.4.1.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.1.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.1.3.3. KEY CONCLUSIONS
6.4.4.1.4. MIDDLE EAST & AFRICA
6.4.4.1.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.1.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.1.4.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ALLOSOURCE
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. BAXTER INTERNATIONAL
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. DEPUY SYNTHES
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. JOHNSON & JOHNSON
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. MEDTRONIC PLC
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. SIGMAGRAFT
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. NUVASIVE, INC.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. ORTHOFIX HOLDINGS, INC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. ORTHOVITA, INC
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. STRYKER CORPORATION
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. SMITH & NEPHEW, INC.
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. WRIGHT MEDICAL GROUP N.V.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. XTANT MEDICAL HOLDINGS, INC
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ZIMMER BIOMET HOLDINGS, INC.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
 
TABLE LIST
 
1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE 2014-2023($ MILLION)
2 GLOBAL ALLOGRAFTS BY GEOGRAPHY 2014-2023 ($ MILLION)
3 GLOBAL BONE GRAFT SUBSTITUTES BY GEOGRAPHY 2014-2023 ($ MILLION)
4 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION 2014-2023 ($ MILLION)
5 GLOBAL SPINAL FUSION BY GEOGRAPHY 2014-2023 ($ MILLION)
6 GLOBAL LONG BONE BY GEOGRAPHY 2014-2023 ($ MILLION)
7 GLOBAL FOOT AND ANKLE BY GEOGRAPHY 2014-2023 ($ MILLION)
8 GLOBAL CRANIOMAXILOFACIAL BY GEOGRAPHY 2014-2023 ($ MILLION)
9 GLOBAL JOINT RECONSTRUCTION BY GEOGRAPHY 2014-2023 ($ MILLION)
10 GLOBAL DENTAL BY GEOGRAPHY 2014-2023 ($ MILLION)
11 NORTH AMERICA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
12 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
13 ASIA PACIFIC BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
14 REST OF THE WORLD BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
 
 
FIGURES LIST
1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY ALLOGRAFTS 2014-2023 ($ MILLION)
2 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY BONE GRAFT SUBSTITUTES 2014-2023 ($ MILLION)
3 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY SPINAL FUSION 2014-2023 ($ MILLION)
4 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY LONG BONE 2014-2023 ($ MILLION)
5 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY FOOT AND ANKLE 2014-2023 ($ MILLION)
6 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY CRANIOMAXILOFACIAL 2014-2023 ($ MILLION)
7 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY JOINT RECONSTRUCTION 2014-2023 ($ MILLION)
8 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY DENTAL  2014-2023 ($ MILLION)
9 UNITED STATES (U.S.) BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
10 CANADA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
11 UNITED KINGDOM (UK) BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
12 FRANCE BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
13 GERMANY BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
14 SPAIN BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
15 ITALY BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
16 ROE BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
17 INDIA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
18 CHINA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
19 JAPAN BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
20 KOREA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
21 AUSTRALIA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
22 ROW APAC BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
23 LATIN AMERICA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)
24 MENA BONE GRAFTS AND SUBSTITUTE MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion